NLS Pharmaceutics Ltd Stock price
Is NLS Pharmaceutics Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
NLS Pharmaceutics Ltd Stock Analysis
Analyst Opinions
6 Analysts have issued a NLS Pharmaceutics Ltd forecast:
Analyst Opinions
6 Analysts have issued a NLS Pharmaceutics Ltd forecast:
Don't miss a Thing! We will send you all news about NLS Pharmaceutics Ltd directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
NLS Pharmaceutics Ltd. engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders, including narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder(ADHD). The company was founded by Ronald Hafner and Alexander Zwyer in August 2015 and is headquartered in Stans, Switzerland.
| Head office | Switzerland |
| CEO | Mr. Zwyer |
| Employees | 7 |
| Founded | 2015 |
| Website | nlspharma.com |


